Factors associated with improved outcome of inhaled corticosteroid use in COVID-19: A single institutional study

Asthmatics seem less prone to adverse outcomes in coronavirus disease 2019 (COVID-19) and some data shows that inhaled corticosteroids (ICS) are protective. We gathered data on anecdotal ICS and outcomes of patients hospitalized with COVID-19, given there is literature supporting ICS may reduce risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Manfra, Andrew, Chen, Claire, Batra, Kavita, Min Tun, Kyaw, Kioka, Mutsumi John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794212/
https://www.ncbi.nlm.nih.gov/pubmed/36595838
http://dx.doi.org/10.1097/MD.0000000000032420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794212/
https://www.ncbi.nlm.nih.gov/pubmed/36595838
http://dx.doi.org/10.1097/MD.0000000000032420

Ejemplares similares